Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Duloxetine on Valsalva Leak Point Pressure and Quantitative Rhabdosphincter Electromyography Measures in Women With Stress Urinary Incontinence

NCT00190853 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT00190853
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00190853 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Duloxetine on Valsalva Leak Point Pressure and Quantitative Rhabdosphincter Electromyography Measures in Women With Stress Urinary Incontinence
Lead sponsor
Eli Lilly and Company
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2005
Completion date
September 30, 2006
Enrollment
93
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

urinary stress incontinence